Doctor Suzette Delaloge

Dr Suzette Delaloge is a medical oncologist and researcher, holding a Doctor of Medicine (MD) and a Master of Science (MSc). She specialises in breast cancer and cancer prevention and works within the Department of Oncology at Gustave Roussy. She trained in France and Canada. She led the breast cancer group at Gustave Roussy from 2004 to 2021. In 2021, she was appointed Director of the personalised prevention programme "Interception" at Gustave Roussy. This visionary initiative establishes clinical pathways at a national level, as well as multidisciplinary research in fundamental, translational, sociological, digital, and clinical fields at national and European levels, to promote early detection and personalised prevention for individuals at high risk of cancer.

Dr Delaloge's main areas of expertise are precision cancer prevention based on risk, real-world data, precision breast cancer oncology, and the organisation of oncology care.

She was President of the French National Breast Cancer Research Group (UCBG) from 2015 to 2019. She chaired the ESMO Breast Cancer Conference from 2022 to 2024. She has been involved in numerous national and European scientific committees and advisory boards. She is President of the Educational Committee of the American Society of Clinical Oncology (ASCO) in the field of cancer prevention and early detection for 2025. She chaired the national project "Unicancer ESME-Metastatic Breast Cancer Real World Data" from 2016 to 2023. She was Vice-President of the ESMO Working Group on Real-World Data and Digital Medicine until December 2024 and has chaired the ESMO Working Group on Precision Prevention in Oncology since that time.

She chairs and coordinates the large-scale MyPeBS project, funded by the EU under the H2020 programme, as well as the clinical trial aimed at demonstrating the value of risk-based breast cancer screening in more than 53,000 women randomised across six European countries, with participation from 27 international partners. She leads several actions and work packages within the European joint actions EUCAn Screen, JAPrevent, and JA Precision Medicine. She chairs the Tiers Lieu Interception project, funded by the Banque des Territoires-France 2030 under the direction of the Agency for Health Innovation.

Dr Delaloge has authored more than 370 peer-reviewed international publications and over 900 presentations at international conferences (Scopus H-Index: 76). In 2019, she was named "Chevalier de la Légion d'Honneur" by the French government and in 2025, "Officier de l'Ordre du Mérite". She won the "Grand Prix de la Recherche Ruban Rose" in 2024.

She is a specialist editor in breast cancer for the European Journal of Cancer, a genetic editor for The Breast, an editor for the ESMO Handbook of Cancer Prevention, an associate editor for ESMO Real World Data and the Digital Health Journal, as well as a reviewer for numerous prestigious journals. She has been involved in professional guideline activities in oncology for many years. Dr Delaloge also participates in numerous continuing education activities for trainee doctors and medical students.